Rasonque Tablet, Film Coated
Product Images NDC 85219-104

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rasonque (NDC 85219-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Revolution Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rasonque 01)

Chemical structure of daraxonrasib, the active ingredient in RASONQUE. The diagram displays the detailed molecular configuration including rings, bonds, and stereochemistry symbols for this oral tablet form drug.*

FDA Label Image

Figure 2 (Rasonque 02)

A Kaplan-Meier survival curve comparing overall survival probability over time in months between treatment groups RASONQUE and SOC Chemotherapy. The plot shows survival probability on the y-axis and time from randomization on the x-axis, with censored data points marked. Below the graph, a table provides the number of patients at risk in each group over time.*

FDA Label Image

Figure 2 (Rasonque 03)

A Kaplan-Meier survival curve chart comparing progression-free survival probability over time from randomization (in months) between two treatment groups: RASONQUE and SOC Chemotherapy. The chart shows higher survival probabilities for the RASONQUE group across most time points, with censored data points marked. The number of patients at risk at various months is also listed below the x-axis for both groups.*

FDA Label Image

Label (100 mg)

RASONQUE 100 mg (daraxonrasib) film-coated tablets label showing the product name, strength, dosage form, and quantity of 30 tablets. The label includes storage instructions, manufacturer Revolution Medicines, Inc., and an NDC code 85219-101-01. It also features a barcode, lot, and expiration date placeholders.*

FDA Label Image

Carton (100 mg)

Packaging label of RASONQUE 100 mg film-coated tablets, containing daraxonrasib. The box states the product contains 30 tablets and is for oral use. It features storage instructions and a caution to keep away from children. The labeler is Revolution Medicines, Inc., with manufacturing information included. The design uses white, orange, and blue colors with the Revolution Medicines logo.*

FDA Label Image

Label (150 mg)

Label for RASONQUE (daraxonrasib) tablets 150 mg, a prescription oral film-coated tablet. The label indicates a count of 30 tablets, along with storage instructions and manufacturer information for Revolution Medicines, Inc. The label includes an NDC number and space for lot and expiration dates.*

FDA Label Image

Carton (150 mg)

Packaging label for RASONQUE 150 mg film-coated tablets containing daraxonasib, a prescription oral medication. The label indicates a count of 30 tablets per container and features the Revolution Medicines logo. Storage instructions and cautions about the inner seal and child safety are included. The product is manufactured for Revolution Medicines, Inc. in California, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.